glp 1 for cardiovascular health GLP-1 and the system The Cardiovascular Biology of Glucagon-like

Clinical and experimental studies demonstrate that GLP-1RAs decrease hepatic fat content and fibrosis markers, reduce circulating pro-inflammatory cytokines, and promote favorable adipokine profiles, collectively dampening immune activation [9,25]

DMSA treatment is recommended as a single agent therapy only and multiple chelating agents used simultaneously have not been evaluated to any large extent in humans and accordingly is NOT RECOMMENDED

Like all medications, GLP-1 drugs can cause some side effects

Huguenard et al., 2022)

The impact of obesity on the prevalence and complications of perianal fistulas of Crohns disease

Decreased NAD + levels in white and brown adipose tissues were associated with impaired heat production and energy metabolism in brown adipose tissue [80]